Evidence map›Paper›PMID 39706662›Full record

ArticleThe Lancet. Global health2025

Global burden of tuberculous meningitis in children aged 0-14 years in 2019: a mathematical modelling study.

Karen du Preez, Helen E Jenkins, Leonardo Martinez, Silvia S Chiang, Sicelo S Dlamini, Mariia Dolynska, Andrii Aleksandrin, Julia Kobe, Stephen M Graham, Anneke C Hesseling and 3 more

Abstract read
In one paragraph

Article in The Lancet. Global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Clinical characteristics and risk factors of severe pulmonary tuberculosis in children in Yunnan, China.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Observational
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Karen du PreezDesmond Tutu Tuberculosis Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa. Electronic address: karendp@sun.ac.za.
Helen E JenkinsDepartment of Biostatistics, School of Public Health, Boston University, Boston, MA, USA.
Leonardo MartinezDepartment of Epidemiology, School of Public Health, Boston University, Boston, MA, USA.
Silvia S ChiangDivision of Pediatric Infectious Diseases, Department of Pediatrics, Alpert Medical School, Brown University, Providence, RI, USA; Center for International Health Research, Rhode Island Hospital, Providence, RI, USA.
Sicelo S DlaminiResearch, Information Monitoring, Evaluation, and Surveillance of the National Tuberculosis Management Cluster, Department of Health, Pretoria, South Africa.
Mariia DolynskaInfection Control in Ukraine, Kyiv, Ukraine.
Andrii AleksandrinInfection Control in Ukraine, Kyiv, Ukraine.
Julia KobeDepartment of Biostatistics, School of Public Health, Boston University, Boston, MA, USA.
Stephen M GrahamDepartment of Paediatrics and Murdoch Children's Research Institute, Royal Children's Hospital, University of Melbourne, Melbourne, VIC, Australia; Burnet Institute, Melbourne, VIC, Australia.
Anneke C HesselingDesmond Tutu Tuberculosis Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
Jeffrey R StarkeDivision of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
James A SeddonDesmond Tutu Tuberculosis Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa; Department of Infectious Disease, Imperial College London, London, UK.
Peter J DoddSheffield Centre for Health and Related Research, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.

Funding

Interdisciplinary and multi-level approach to estimate the disease burden and outcomes of childhood tuberculous meningitis.K43TW011006 · FIC · STELLENBOSCH UNIVERSITY · PI DU PREEZ, KAREN · 2020 to 2024
$622k
Tracking tuberculosis patients in Ukraine to understand pathways through care and the impact of geographic movementsR03AI164123 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI JENKINS, HELEN E. · 2021 to 2022
$165k
FIC NIH HHS K43 TW011006NIAID NIH HHS R03 AI164123
6 · The paper itself

Abstract

backgroundTuberculous meningitis is fatal if untreated and can lead to lifelong neurological sequelae. However, to our knowledge, there are no data on the number of children affected by this disease. We aimed to estimate the global disease burden and attributable mortality of childhood tuberculous meningitis by WHO regions, age groups, treatment status, and HIV status in 2019.

methodsWe developed a Bayesian mathematical model to estimate the number of children aged 0-14 years who developed tuberculous meningitis, died from tuberculous meningitis, and did not die from tuberculous meningitis but had neurological sequelae in 2019. We reviewed the literature and used meta-analyses to quantify key parameters used as model inputs: risk of tuberculous meningitis after Mycobacterium tuberculosis infection, tuberculous meningitis as a proportion of tuberculosis notification data (ie, routine surveillance data that countries report to WHO), and risk ratios for tuberculous-meningitis mortality by age group. We identified routine tuberculosis surveillance data from countries and literature that reported the proportion of notified childhood tuberculosis that was due to tuberculous meningitis. Country-level data were from Brazil; the USA; Ukraine; South Africa; and the European Centre for Disease Prevention and Control, which included 29 countries but was aggregated and considered as one site. We assumed tuberculosis notification was synonymous with detection and treatment, combined age-disaggregated risk ratios and published meta-analytic estimates of the case-fatality rate in children who received treatment to produce estimates of tuberculous-meningitis mortality by age group and HIV status, and assumed that untreated tuberculous meningitis was always fatal. We assumed similar age-disaggregated risk ratios for neurological sequelae among children who had treatment for tuberculous meningitis and lived as for children who died.

findingsAn estimated 24 000 (95% credible interval 22 300-25 700) children younger than 15 years developed tuberculous meningitis in 2019. Of these children, 13 000 (12 100-13 900) were estimated to have been diagnosed and treated for tuberculous meningitis. Most untreated children were younger than 5 years. Among the 24 000 children with tuberculous meningitis, 16 100 (14 900-17 300) were estimated to have died in 2019, of whom 1101 (6·8%) had HIV. 13 380 (83·1%) of 16 100 deaths were estimated to be in children younger than 5 years and 11 000 (68·3%) were estimated to be in children who did not receive tuberculous-meningitis treatment. Of the 7900 (5800-10 000) children who did not die, 5550 (5110-5980) were estimated to have neurological sequelae.

interpretationOur estimates of tuberculous meningitis in children younger than 15 years showed substantial mortality and morbidity. Improved diagnostics and strong health-care systems to facilitate early diagnosis are crucial to improve outcomes, and tuberculosis prevention should be a public health priority.

fundingFogarty International Center of the US National Institutes of Health.

Indexed as

Global HealthModels, TheoreticalTuberculosis, MeningealAdolescentBayes TheoremChildChild, PreschoolFemaleGlobal Burden of DiseaseHIV InfectionsHumansInfantInfant, NewbornMale

Identifiers

PMID39706662
PMCPMC11729397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.